Oman
Tuberculosis profile
Population  2013 3.6 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.025 (0–0.25) 0.69 (0–6.9)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.04)
Prevalence  (includes HIV+TB) 0.46 (0.17–0.9) 13 (4.7–25)
Incidence  (includes HIV+TB) 0.39 (0.37–0.43) 11 (10–12)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.16 (0.15–0.18)
Case detection, all forms (%) 84 (76–90)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.89 (0.11–3.2) 0 (0–52)
MDR-TB cases among notified pulmonary
TB cases
2 (0–7) 0 (0–3)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 224   5
Pulmonary, clinically diagnosed 0   0
Extrapulmonary 101   0
       
Total new and relapse 330    
Previously treated, excluding relapses 0    
Total cases notified 330    
Among 330 new and relapse cases:
16 (5%) cases aged under 15 years; male:female ratio: 1.4
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 263 (117%) 5 (100%) 268
Laboratory-confirmed RR-/MDR-TB cases     3
Patients started on MDR-TB treatment     2
TB/HIV 2013 Number (%)
TB patients with known HIV status 330 (100)
HIV-positive TB patients 5 (2)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 5 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 5 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 97
Previously treated cases, excluding relapse, registered in 2012 100
HIV-positive TB cases, all types, registered in 2012 100
RR-/MDR-TB cases started on second-line treatment in 2011 100
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-04-25 Data: www.who.int/tb/data